ZEVRA THERAPEUTICS, INC. — Director's Dealing 2021

Nov 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: KEMPHARM, INC (KMPH)
CIK: 0001434647
Period of Report: 2021-11-18

Reporting Person: Mickle Travis C (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-18	Common Stock	P	2250	$8.2295	Acquired	36521	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	15242	Indirect
Common Stock	1034	Indirect
Common Stock	9824	Indirect
Common Stock	96153	Indirect

Footnotes

F1: The Reporting Person is the sole manager member of Mickle Investments, LLC.

F2: The Reporting Person is the sole manager member of Mickle Holdings, LLC.